As a case study, we applied Pi-ATAC to the fast growing and highly invasive MMTV-PyMT genetically engineered mouse breast tumor model25 to simultaneously dissect EpCAM+ tumor cells and tumor-infiltrating immune cells (CD45+) (Fig. 3a, Methods). This evidence concerns the gene PTPRC and breast neoplasm.